Investigation of peptomimetics of GD2 antibodies as targeted therapy against human small cell lung cancer in-vitro

13128 Background: GD2 is a well-established target that has been validated for neuroblastoma and small cell lung cancer. The therapeutic and diagnostic use of monoclonal antibodies directed to GD2 ...